Join us for an engaging discussion featuring Dr. Rohit Aggarwal, Principal Investigator of the Myositis Interstitial Lung Disease Nintedanib Trial (MINT) at the University of Pittsburgh. This session will explore the practical application and benefits of mobile visits in decentralized clinical trials (DCTs) through the eyes of a leading PI actively managing a randomized study on Interstitial Lung Disease. Key members from the University of Pittsburgh and PCM Trials will join in to discuss the implementation, challenges, and successes of bringing clinical trials directly to patients’ homes. Attendees will gain firsthand insights into the successful adoption of DCT strategies and receive actionable advice for those interested in implementing them in their own studies.
Learning objectives:
- Understand the practical applications and benefits of mobile visits.
- Hear directly from the study team about their experiences incorporating mobile visits into the design and execution of an interstitial lung disease study.
- Identify common challenges faced by PIs, study coordinators, and project managers when adopting DCTs and the innovative solutions used to overcome these hurdles.
- Obtain practical advice for academic centers and researchers considering decentralized trial designs.